[go: up one dir, main page]

WO2000058519A3 - Caracterisation de polymorphismes d'un seul nucleotide, dans des regions de codage de genes humains - Google Patents

Caracterisation de polymorphismes d'un seul nucleotide, dans des regions de codage de genes humains Download PDF

Info

Publication number
WO2000058519A3
WO2000058519A3 PCT/US2000/008440 US0008440W WO0058519A3 WO 2000058519 A3 WO2000058519 A3 WO 2000058519A3 US 0008440 W US0008440 W US 0008440W WO 0058519 A3 WO0058519 A3 WO 0058519A3
Authority
WO
WIPO (PCT)
Prior art keywords
charaterization
single nucleotide
coding regions
nucleotide polymorphisms
human genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/008440
Other languages
English (en)
Other versions
WO2000058519A2 (fr
Inventor
David Altshuler
Michele Cargill
George Q Daley
Jams S Ireland
Eric S Lander
Rober Tj Lipshutz
Nila Patil
Pamela Sklar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Affymetrix Inc
Whitehead Institute for Biomedical Research
Original Assignee
Affymetrix Inc
Whitehead Institute for Biomedical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affymetrix Inc, Whitehead Institute for Biomedical Research filed Critical Affymetrix Inc
Priority to AU40500/00A priority Critical patent/AU4050000A/en
Publication of WO2000058519A2 publication Critical patent/WO2000058519A2/fr
Publication of WO2000058519A3 publication Critical patent/WO2000058519A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne des segments d'acides nucléiques du génome humain, notamment des segments d'acides nucléiques provenant de la région de codage d'un gène, y compris des sites polymorphes. L'invention concerne également des amorces et sondes, spécifiques d'allèles, et s'hybridant à des régions flanquant ces sites ou contenant ceux-ci. On utilise ces acides nucléiques, amorces et sondes dans des applications telles que des corrélations de phénotypes, dans la médecine légale, la recherche de paternité, la médecine et l'analyse génétique.
PCT/US2000/008440 1999-03-31 2000-03-30 Caracterisation de polymorphismes d'un seul nucleotide, dans des regions de codage de genes humains Ceased WO2000058519A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU40500/00A AU4050000A (en) 1999-03-31 2000-03-30 Charaterization of single nucleotide polymorphisms in coding regions of human genes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12724899P 1999-03-31 1999-03-31
US60/127,248 1999-03-31

Publications (2)

Publication Number Publication Date
WO2000058519A2 WO2000058519A2 (fr) 2000-10-05
WO2000058519A3 true WO2000058519A3 (fr) 2001-08-23

Family

ID=22429104

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/008440 Ceased WO2000058519A2 (fr) 1999-03-31 2000-03-30 Caracterisation de polymorphismes d'un seul nucleotide, dans des regions de codage de genes humains

Country Status (2)

Country Link
AU (1) AU4050000A (fr)
WO (1) WO2000058519A2 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6949633B1 (en) 1995-05-22 2005-09-27 Sequenom, Inc. Primers useful for sizing nucleic acids
US6958214B2 (en) 2000-07-10 2005-10-25 Sequenom, Inc. Polymorphic kinase anchor proteins and nucleic acids encoding the same
US7432342B2 (en) 2002-05-03 2008-10-07 Sequenom, Inc. Kinase anchor protein muteins, peptides thereof and related documents
CN108048575A (zh) * 2017-11-03 2018-05-18 湖南优品司生物科技有限公司 一种用于产前无创亲子鉴定的试剂盒及方法

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1294934A2 (fr) 2000-03-08 2003-03-26 Complexe Hospitalier de la Sagamie Polymorphismes de recepteurs de lipoproteines tres basse densite et utilisations associees
WO2002012499A2 (fr) * 2000-08-04 2002-02-14 Genaissance Pharmaceuticals, Inc. Haplotypes du gene ntf3
AU2001294586A1 (en) * 2000-09-15 2002-03-26 Genaissance Pharmaceuticals, Inc. Haplotypes of the htr5a gene
US20030087244A1 (en) * 2001-10-09 2003-05-08 Vitivity, Inc Diagnosis and treatment of vascular disease
US7332597B2 (en) 2004-06-28 2008-02-19 University Of Kentucky Research Foundation Primers and probe to identify mycobacterium tuberculosis complex
CA2915679C (fr) * 2006-10-20 2017-12-12 Celera Corporation Polymorphismes genetiques associes a la thrombose veineuse, procedes pour les detecter et utilisations

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996020279A1 (fr) * 1994-12-23 1996-07-04 Ribozyme Pharmaceuticals, Inc. Procede et reactif destines a la prevention, a l'inhibition de la progression et a la regression des maladies vasculaires
WO1998020165A2 (fr) * 1996-11-06 1998-05-14 Whitehead Institute For Biomedical Research Marqueurs bialleliques

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996020279A1 (fr) * 1994-12-23 1996-07-04 Ribozyme Pharmaceuticals, Inc. Procede et reactif destines a la prevention, a l'inhibition de la progression et a la regression des maladies vasculaires
US5705388A (en) * 1994-12-23 1998-01-06 Ribozyme Pharmaceuticals, Inc. CETP Ribozymes
WO1998020165A2 (fr) * 1996-11-06 1998-05-14 Whitehead Institute For Biomedical Research Marqueurs bialleliques

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
CHEE M ET AL: "ACCESSING GENETIC INFORMATION WITH HIGH-DENSITY DNA ARRAYS", SCIENCE,US,AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, vol. 274, 25 October 1996 (1996-10-25), pages 610 - 614, XP002022508, ISSN: 0036-8075 *
DATABASE GENEBANK 18 April 1992 (1992-04-18), ICHINOSE H. ET AL.: "Molecular cloning of genomic DNA and chromosomal assignment of the gene for human aromatic L-amino acid decarboxylase", XP002152538 *
DATABASE MEDLINE American medical association; 3 March 1992 (1992-03-03), XP002152537 *
OEFNER P J ET AL: "COMPARATIVE DNA SEQUENCING BY DENATURING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY", AMERICAN JOURNAL OF HUMAN GENETICS,UNIVERSITY OF CHICAGO PRESS, CHICAGO,,US, vol. 57, October 1995 (1995-10-01), pages A266, XP002918646, ISSN: 0002-9297 *
SUMI-ICHINOSE C. ET AL.: "Molecular cloning of genomic DNA and chromosomal assignment of the gene for human aromatic L-amino acid decarboxylase, the enzyme for catecholamine and serotonine biosynthesis", BIOCHEMISTRY, vol. 31, no. 8, 1992, US, pages 2229 - 2238, XP000943412, DOI: doi:10.1021/bi00123a004 *
SYVANEN A -CH ET AL: "IDENTIFICATION OF INDIVIDUALS BY ANALYSIS OF BIALLELIC DNA MARKERS,USING PCR AND SOLID-PHASE MINISEQUENCING", AMERICAN JOURNAL OF HUMAN GENETICS,US,UNIVERSITY OF CHICAGO PRESS, CHICAGO,, vol. 52, no. 1, 1993, pages 46 - 59, XP002050638, ISSN: 0002-9297 *
UNDERHILL P.A. ET AL.: "Detection of numerous Y chromosome biallelic polymorphisms by denaturing high-performance liquid chromatography", GENOME RESEARCH, vol. 7, - 1997, US, pages 996 - 1005, XP000942730 *
WANG D G ET AL: "Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome", SCIENCE,US,AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, vol. 280, 1998, pages 1077 - 1082, XP002089398, ISSN: 0036-8075 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6949633B1 (en) 1995-05-22 2005-09-27 Sequenom, Inc. Primers useful for sizing nucleic acids
US6958214B2 (en) 2000-07-10 2005-10-25 Sequenom, Inc. Polymorphic kinase anchor proteins and nucleic acids encoding the same
US7432342B2 (en) 2002-05-03 2008-10-07 Sequenom, Inc. Kinase anchor protein muteins, peptides thereof and related documents
CN108048575A (zh) * 2017-11-03 2018-05-18 湖南优品司生物科技有限公司 一种用于产前无创亲子鉴定的试剂盒及方法
CN108048575B (zh) * 2017-11-03 2021-06-15 中南大学湘雅医院 一种用于产前无创亲子鉴定的试剂盒及方法

Also Published As

Publication number Publication date
AU4050000A (en) 2000-10-16
WO2000058519A2 (fr) 2000-10-05

Similar Documents

Publication Publication Date Title
WO1998020165A3 (fr) Marqueurs bialleliques
WO2001066800A3 (fr) Polymorphismes humains a nucleotide unique
CA2289872A1 (fr) Reactions dependant de la cible faisant appel a des oligonucleotides formant des ponts avec des structures
WO2001077384A3 (fr) Detection de polymorphismes du nucleotide simple et de methylation de cytosine
EP2341057A3 (fr) Analogues d'oligonucléotides
WO2001047944A3 (fr) Acides nucleiques contenant des polymorphismes mononucleotidiques et procedes d'utilisation correspondants
WO1999050454A3 (fr) Polymorphismes de sequences de codage dans des genes de pathologie vasculaire
WO2000047771A3 (fr) Marqueurs bialleles derives de regions genomiques porteuses de genes intervenant dans le metabolisme de l'acide arachidonique
EP1212449A4 (fr) Amplification de sequences flanquantes a partir d'adn inconnu
WO2000058519A3 (fr) Caracterisation de polymorphismes d'un seul nucleotide, dans des regions de codage de genes humains
WO2001018250A3 (fr) Polymorphismes a nucleotide unique des genes
DE69816467D1 (de) Robo: eine familie polypeptiden und nukleinesäuren wirksam in nervenzellleitung
WO2001051659A3 (fr) Marqueurs bialleles derives de regions genomiques comportant des genes responsables de troubles du systeme nerveux central
WO2001042511A3 (fr) Polymorphismes associes aux maladies enteriques inflammatoires
ATE427362T1 (de) Polymorphe marker des lsr-gens
WO2001038576A3 (fr) Polymorphismes humains a nucleotide unique
AU4766000A (en) Method for analysing a patient's genetic predisposition to at least a disease and amplification adapted to such a method
WO1999054500A3 (fr) Marqueurs bialleles convenant a la constitution d'une carte haute densite des desequilibres du genome humain
HAUSWALDT* et al. Nine new tetranucleotide microsatellite markers for the fire‐bellied toad (Bombina bombina)
WO1999053095A3 (fr) Marqueurs bialleliques
CA2348828A1 (fr) Sequences genomiques et d'adnc complet de l'apm1 et marqueurs bialleliques connexes
WO2003054167A3 (fr) Identification de sites polymorphes dans le gene humain mglur8 et utilisations associees
EP1262565A3 (fr) Polymorphismes génétiques dans le gène humain du récepteur de la neurokinine 1 et leurs usages dans diagnostic et traitement de maladies
WO2000058508A3 (fr) Marqueurs bialleliques relatifs aux genes impliques dans le metabolisme des medicaments
WO2001023410A3 (fr) Isogenes cibles a usage medicamenteux: polymorphismes dans le gene d'interleukine

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP